GLP-1 RAs are drugs that have made a significant impact in recent years for diabetes and weight management.
 Their established effects in glycemic management, cardiovascular protection, and weight loss are prompting shifts in clinical practice and guideline recommendations.  With the prevalent number of GLP-1 RAs currently on the Canadian market and more in development,
 it is imperative that all healthcare providers be comfortable and confident in educating and assisting individuals who use these medications. In this dynamic session, we will demonstrate how pharmacists in the community can seamlessly integrate their clinical
 expertise on GLP-1 RAs into their patient care routines and workflow.  

Sponsored by: Novo Nordisk